[Experience with preventive measles, mumps and rubella vaccination in unified Germany]
- PMID: 8435543
[Experience with preventive measles, mumps and rubella vaccination in unified Germany]
Abstract
Considerable immunity gaps in respect of mumps and rubella (German measles) of up to 30% among pupils of the prepuberty age are the requisite arguments in favour of the need for vaccination measures. Combined protective vaccination with live attenuated measles-mumps-rubella vaccine without preceding laboratory tests is recommended for practical reasons and economy. No side effects have been seen on renewed protective vaccination with live attenuated measles vaccine in case of already existent natural immunity. A booster effect can be demonstrated in vaccinated persons with low or borderline antibody levels. Revaccination from the 6th year of life onwards is recommended and advocated to close existing vaccination and immunity gaps.
Similar articles
-
[Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].Schweiz Med Wochenschr. 1985 Nov 30;115(48):1727-30. Schweiz Med Wochenschr. 1985. PMID: 4081704 Clinical Trial. German.
-
[Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].An Esp Pediatr. 1987 Jul;27(1):27-31. An Esp Pediatr. 1987. PMID: 3662251 Spanish.
-
[Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].Minerva Pediatr. 1989 Mar;41(3):117-22. Minerva Pediatr. 1989. PMID: 2747598 Italian.
-
[Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].Ugeskr Laeger. 1992 Jul 13;154(29):2008-13. Ugeskr Laeger. 1992. PMID: 1509566 Review. Danish.
-
[Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].An Esp Pediatr. 1992 Apr;36(4):293-7. An Esp Pediatr. 1992. PMID: 1605414 Review. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical